Search / Trial NCT06223464

Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix

Launched by ANKARA ETLIK CITY HOSPITAL · Jan 23, 2024

Trial Information

Current as of December 21, 2024

Active, not recruiting

Keywords

Adenomyosis Elastography Cervical

ClinConnect Summary

Adenomyosis is the proliferation of endometrial gland and stroma within the myometrium of the uterus. Its prevalence varies between 10% and 40% in epidemiologic data. It often causes painful menstruation, pelvic pain and other gynecologic symptoms. While adenomyosis may be mild in some patients, it may show infiltrative and severe invasion in others. Advanced cases may be resistant to medical treatment and may affect nearby organs, which makes surgical treatment quite complicated. Therefore, early diagnosis of the disease is important for clinical practice. Global enlargement of the uterus,...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female patients between 18-45 years of age who volunteered and consented to the reproductive period study
  • Patients diagnosed with adenomyosis using MUSA criteria
  • Exclusion Criteria:
  • Pregnancy status
  • Pelvic/Cervical infection, pathology and anomalies
  • History of cervical surgery
  • Diagnosis and findings of systemic disease
  • Chronic drug use
  • Advanced maternal obesity preventing measurement

About Ankara Etlik City Hospital

Ankara Etlik City Hospital is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital emphasizes a multidisciplinary approach, leveraging its state-of-the-art facilities and a team of experienced healthcare professionals. With a commitment to ethical practices and patient safety, Ankara Etlik City Hospital aims to contribute to the global medical community by facilitating research that enhances treatment options and health outcomes across various therapeutic areas.

Locations

Ankara, Yenimahalle, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0